One potentially modifiable risk factor for CVD in patients with CKD is dyslipidemia. In the current manuscript we review observational and trial data assessing dyslipidemia and its treatment in ...

Virtually all studies have shown very high safety profiles for nutritional supplements in the treatment of dyslipidemia. In the section below, all the efficacy studies, adverse effects and safety ...